Back To Schedule
Wednesday, October 21 • 08:00 - 09:00
The Peoples Vaccine: Intellectual Property and Access to Medicines in the Age of COVID-19

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

This presentation explores intellectual property and access to medicines in the age of COVID-19 and vaccine nationalism. It will consider the campaign led by Winnie Byanyima of UNAIDS for the development of a People's Vaccine. The WHO has established the ACT Accelerator in order to boost research, development, and deployment of COVID-19 technologies. Costa Rica proposed a COVID-19 Technology Access Pool - which has been taken up by the WHO. The Medicines Patent Pool has expanded its jurisdiction to include the sharing of IP related to COVID-19. There has also been discussion of the use of compulsory licensing and crown use to counteract profiteering and anti-competitive behavior. There has been a push by UAEM and others for the public licensing of COVID-19 technologies developed with government funding. The Open COVID Pledge has been taken by a number of intellectual property owners. In response to the assertion of proprietary rights in respect of COVID-19 technologies, the open movement has championed the development of Open Science models of science. India and South Africa have put forward a waiver proposal in the TRIPS Council to enable countries to take action in respect of COVID-19 without fear of retribution under trade laws.

(If you miss the talk, you can watch an earlier version - The People’s Vaccine: IP, Access to Medicines, and the Coronavirus #COVID19 https://youtu.be/va5pmrlg0VU via @YouTube)

avatar for Matthew Rimmer

Matthew Rimmer

Professor of Intellectual Property and Innovation Law, Faculty of Business and Law, QUT
Dr Matthew Rimmer is a Professor in Intellectual Property and Innovation Law at the Faculty of Business and Law, at the Queensland University of Technology (QUT). He has published widely on copyright law and information technology, patent law and biotechnology, access to medicines... Read More →

W669 pdf

Wednesday October 21, 2020 08:00 - 09:00 UTC